Reimbursement

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the March 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). A favorable opinion was issued on the add-on reimbursement for three new devices in the gastrointestinal endoscopy, men’s health, and orthopedics fields.

On March 26, 2026, NHS England published the final version of the 2026/27 NHS Payment Scheme, effective from April 1, 2026. While the overall payment model remains largely unchanged, several targeted updates have been introduced. These include new blended payments for urgent and emergency care, radiotherapy, and genomic testing, as well as two new Best Practice Tariffs (BPTs) to incentivize day case procedures and support 10 Year Health Plan referral-to-treatment (RTT) priorities.

In March 2026, the Dutch Healthcare Authority (NZa) published regulations on the budgetary funding for emergency care. The final financial result is determined by the revenue from the provisional budget (set in advance) and the final budget (determined after the end of the year). A new supplementary payment with a fixed, provider-specific tariff will be introduced for the billing and calculation of budgets of ER departments. The regulations enter into force on July 1, 2026.

In March 2026, the SwissDRG, the entity managing the DRG system in Switzerland, announced that it would be accepting applications for changes from June 1, 2026, until July 13, 2026. The results of the DRG applications made in 2026 will be reflected in the 2028 version of the SwissDRG.

On March 6, 2026, the German Bundestag adopted amendments to the hospital reform. The core objectives of the reform remain unchanged: consolidating services, increasing specialization, and thereby improving the quality of healthcare delivery. The adjustments primarily aim to ensure the practical implementation of the measures, with a particular focus on maintaining inpatient care, especially standard and emergency care, in rural areas.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the February 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Favourable opinions were issued on the add-on reimbursement for six new devices and on the extension of indications for two devices, in the cardiovascular, peripheral vascular, and ENT fields.

On February 13, 2026, the Ministry of Health published an experimental version (so-called "Gamma") of new classification systems for diagnosis and procedure coding under the NSIS-CLASS project, launching the transition from ICD-9-CM. These systems will become mandatory for coding diagnoses and procedures from January 1, 2027, following a testing phase and the release of the final (“Delta”) versions by the end of 2026, with updates planned at least every two years.

A new version of the Nomenclature of Medical Biology Procedures (NABM 102), effective from March 3, 2026, was published in France. Changes include the introduction of one new code and the deletion and modification of several codes.

In Germany, digital health applications (DiGAs) that can be prescribed by physicians and psychotherapists and reimbursed by statutory health insurers are listed in the Directory of Digital Health Applications maintained by the Federal Institute for Drugs and Medical Devices (BfArM). As of February 23, 2026, a total of 61 apps are available in the Directory and thus eligible for reimbursement.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the January 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). A favourable opinion was issued on the add-on reimbursement for one new device, as well as on the extension of indications for two devices for transcatheter aortic valve implantation.

On January 13, 2026, a new version of the Nomenclature of Medical Biology Procedures (NABM 101) was published in France. A new chapter for constitutional genetics was introduced, including two new codes.

On January 14, 2026, the French Ministry of Health, Family, Autonomy and People with Disability published the Order setting DRG tariffs and tariffs for other packages and supplements for 2026. The released tariffs are in effect from January 1, 2026, and include new, higher DRG tariffs for several procedures, such as HIFU destruction of prostate lesions, as well as updates to packages for organ perfusion technologies for transplantation.